With the continuous expansion of the market size of Chinese herbal medicine decoction pieces, ensuring high-quality development has become a top priority

Chinese medicinal pieces refer to Chinese medicinal materials and processed processed products of Chinese medicinal materials that can be directly used for compounding or preparation under the guidance of the theory of Chinese medicine
.
According to statistics, the market size of Chinese herbal medicine decoction pieces in 2018 is about 220 billion yuan
.
According to the current development trend, the market size of Chinese herbal medicine decoction pieces in 2021 is expected to reach 264.
67 billion yuan
.
It is worth mentioning that although the market space of the traditional Chinese medicine decoction pieces industry is broad, in recent years, the exogenous harmful residues caused by environmental pollution and irregular planting have exceeded the standard, the dyeing or adulteration of Chinese medicinal materials and decoction pieces, the lack of processing and storage specifications The quality and safety of Chinese medicine decoction pieces is becoming increasingly prominent due to the influence of factors such as quality out of control
.
For example, in the random inspections conducted on the quality of medicines in many places, Chinese herbal medicine pieces were frequently found to be unqualified
.
It is reported that the 2021 Phase 3 Drug Quality Sampling Notice issued by the Shanghai Food and Drug Administration recently showed that the unqualified drugs in this notice are all traditional Chinese medicine decoction pieces, including Cistanche Tablets, Alisma orientalis, 2 batches of Dandelion and Coptis ; The unqualified items are moisture, extract, traits (worm-eaten), traits
.
It should be noted that the five drug companies that have found unqualified drugs this time also have multiple drug unqualified records
.
Among them, the enterprises with more records of unqualified drugs have a total of 14 records of unqualified drugs, and the dosage forms of unqualified drugs are basically traditional Chinese medicine decoction pieces
.
At present, the Shanghai Drug Administration has organized relevant regulatory authorities to take control measures on the notified products and investigate and deal with them in accordance with the law, requiring the enterprises or units involved to take control measures such as suspension of sales, use, or recalls based on the level of risk and to find out the reasons and eliminate hidden risks.

.
Industry analysis believes that, in fact, in recent years, market regulatory authorities in various regions have been constantly "strikes out", strengthened special rectification of traditional Chinese medicine decoction pieces, actively promoted standardized production, strengthened supervision of pesticide residues, and regulated the operation and use behavior of traditional Chinese medicine decoction pieces.
Improve the quality of decoction pieces of traditional Chinese medicine
.
However, in this context, the problems of traditional Chinese medicine decoction pieces reported from various places continue to occur, and there are even some large Chinese medicine companies that have problems.
There is still a long way to go to ensure the safety of traditional Chinese medicine decoction pieces.

.
Now that Chinese medicine decoction pieces have become one of the three pillars of China's traditional Chinese medicine industry, how can pharmaceutical companies better protect traditional Chinese medicine decoction pieces when the market has a broad development space and the standardized and healthy development of the industry has reached a crucial stage? What about the high-quality development of the industry? In this regard, the industry proposes that, first of all, all pharmaceutical companies need to further strengthen self-discipline, and strictly follow the requirements of the new version of the pharmacopoeia to do a good job of checking every link of planting, production, processing, and circulation, so as to promote the improvement of the overall quality of the TCM decoction industry
.
In addition, the problem of pesticide residues in decoction pieces of traditional Chinese medicine has always been the core pain point of the industry, and it is also the key difficulty to be solved in the 2020 Chinese Pharmacopoeia
.
Therefore, for manufacturers, improving the ability of independent inspection and testing of Chinese medicine decoction pieces should also be one of the key to solving this problem
.
So, how can Chinese medicine decoction pieces enterprises improve their independent inspection and testing capabilities? On the one hand, it needs the support of pesticide residue inspection and testing equipment
.
On the other hand, companies also need to strengthen the training of relevant high-quality professional testing personnel so that they can operate the testing equipment more proficiently to ensure the scientific and accurate testing results
.
In general, the market for decoction pieces of traditional Chinese medicine has a broad space for development, and the market size is expected to continue to expand in the future
.
But at the same time, the entire Chinese medicine decoction piece industry will also face stricter supervision
.
Faced with this big environment, all enterprises in the traditional Chinese medicine decoction pieces industry need to make more stringent management of their production and operation in order to achieve better development
.